得克萨斯州和佛罗里达州以安全为由,以Mifepristone批准为由,起诉林业发展局,并援引《Comstock法》,试图禁止堕胎药丸。 Texas and Florida sue FDA over mifepristone approval, citing safety and the Comstock Act, seeking to ban the abortion pill.

得克萨斯州和佛罗里达州已经起诉林业发展局批准Mifepristone, 质疑其安全和监管程序, 目的是将堕胎药丸从市场上移除。 Texas and Florida have sued the FDA over its approval of mifepristone, challenging its safety and regulatory process, aiming to remove the abortion pill from the market. 2025年12月9日提起的诉讼援引了1873年的《Comstock法》, The lawsuit, filed December 9, 2025, cites the 1873 Comstock Act and argues the FDA’s decisions were politically driven. 这一举动是反堕胎国家更广泛的法律战略的一部分,即在政治渠道缩小后限制通过法院的渠道。 The move is part of a broader legal strategy by anti-abortion states to restrict access through courts after political avenues narrowed. 该案可能会影响民主各州的堕胎防护法,并遵循以往失败的挑战,包括2024年最高法院因缺乏资格而解雇的案件。 The case could impact abortion shield laws in Democratic states and follows previous failed challenges, including a Supreme Court dismissal in 2024 for lack of standing.